References
- Feingold KR, Elias PM. Endocrine-skin interactions. Cutaneous manifestations of adrenal disease, pheochromocytomas, carcinoid syndrome, sex hormone excess and deficiency, polyglandular autoimmune syndromes, multiple endocrine neoplasia syndromes, and other miscellaneous disorders. J Am Acad Dermatol 1988;19:1–20.
- Karagiannis A, Mikhailidis DP, Athyros VG, Harsoulis F. Pheo: an update on genetics and management. Endocr Relat Cancer 2007;14:935–56.
- Walther MM, Keiser HR, Linehan W. Pheochromocytoma: evaluation, diagnosis, and treatment. World J Urol 1999;17:35–9.
- Hamdan A, Hirsch D, Green P, Neumann A, Drozd T, Molad Y. Pheochromocytoma: unusual presentation of a rare disease. Isr Med Assoc J 2002;4:827–8.
- Liel Y, Zucker G, Lantsberg S, Argov S, Zirkin HJ. Malignant pheochromocytoma stimulating meningioma and metastatic pheochromocytoma in the base of the skull. Isr Med Assoc J 2002;4:829–30.
- Yu R, Nissen NN, Chopra P, Dhall D, Phillips E, Wei M. Diagnosis and treatment of pheochromocytoma in an academic hospital from 1997 to 2007. Am J Med 2009;122:85–95.
- Lin PC, Hsu JT, Chung CM, Chang ST. Pheochromocytoma underlying hypertension, stroke, and dilated cardiomyopathy. Tex Heart Inst J 2007;34:244–6.
- Blanchet P. [Paroxystic vasomotor skin manifestations], in French. Ann Dermatol Venereol 1978;105:1001–7.
- Dany F, Doutre MS, Coupillaud G, Beylot C, Dallocchio M. [Cutaneous manifestation of pheochromocytoma. Report of a case], in French. Sem Hop 1981;57:1223–5.